NZ510672A - Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione - Google Patents

Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione

Info

Publication number
NZ510672A
NZ510672A NZ510672A NZ51067298A NZ510672A NZ 510672 A NZ510672 A NZ 510672A NZ 510672 A NZ510672 A NZ 510672A NZ 51067298 A NZ51067298 A NZ 51067298A NZ 510672 A NZ510672 A NZ 510672A
Authority
NZ
New Zealand
Prior art keywords
composition
thiazolidine
dione
pyridyl
ethoxy
Prior art date
Application number
NZ510672A
Inventor
Hamish Ross
Jai Patel
Jeffrey Roger Granett
Robin Price
Original Assignee
Smithkline Beecham P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9711683.4A external-priority patent/GB9711683D0/en
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Application filed by Smithkline Beecham P filed Critical Smithkline Beecham P
Publication of NZ510672A publication Critical patent/NZ510672A/en

Links

Abstract

A process for the preparation of a pharmaceutical composition that comprises 5-[4-[2-(N-methyl-N- (2-pyridyl) amino) ethoxy ] - benzyl ] thiazolidine-2, 4-dione (compound I) involving the following steps: preparing a first composition of compound I in the range of 5 to 20 % weight and a first pharmaceutical carrier; then admixing the first composition with a second pharmaceutical carrier.
NZ510672A 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione NZ510672A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition
NZ33805198 1998-06-02

Publications (1)

Publication Number Publication Date
NZ510672A true NZ510672A (en) 2002-11-26

Family

ID=27268876

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510672A NZ510672A (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione

Country Status (1)

Country Link
NZ (1) NZ510672A (en)

Similar Documents

Publication Publication Date Title
EA200601145A1 (en) TABLET OF SLOW-DIVISION OF INSULIN SENSITIZER AND OTHER ANTI-DIABETIC AGENTS
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
MY129897A (en) Use of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione and metformin for the treatment of diabetes mellitus
TR200001793T2 (en) The thiazolidinedione derivative, the structure of which has been modified, its use in the process and pharmaceuticals for its preparation
MY135973A (en) Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative
HUP0100509A3 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical, process for its preparation and its pharmaceutical use
TR200002790T2 (en) Composition containing 5- (4- (2- (N-methyl-N-2-pyridyl) amino) ethoxy) benzyl) thiazolidin-2,4-dione
MY129475A (en) Process for the preparation of substituted thiazolidinedione
NZ515555A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
NZ510672A (en) Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione
AP1600A (en) Combination of a thiazolidinedione and a sulphonylurea for treating diabetes
WO2000063205A3 (en) Thiazolidinedione derivative and its use as antidiabetic
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
WO2000063206A3 (en) Thiazolidinedione derivative and its use as antidiabetic
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AU2002343052A1 (en) Rosiglitazone edisylates and their use as antidiabetics
GB0021784D0 (en) Novel pharmaceutical
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AU2001284274A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
YU14503A (en) Novel pharmaceutical
ECSP003434A (en) NEW COMPOUNDS
IL160144A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed